(Q40475415)

20 September 2017

1 reference

title

Clinical issues in antibody design. (English)

1 reference

20 September 2017

Chester KA

1

1 reference

PubMed ID

7662305

20 September 2017

Hawkins RE

series ordinal

2

1 reference

20 September 2017

1 August 1995

1 reference

20 September 2017

Trends in Biotechnology

1 reference

20 September 2017

13

1 reference

20 September 2017

294-300

1 reference

20 September 2017

8

1 reference

Recent developments in the radioimmunotherapy of cancer

20 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

1 reference

7 January 2021

Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Medical applications of single-chain antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Phage antibodies: will new 'coliclonal' antibodies replace monoclonal antibodies?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Phage antibodies: filamentous phage displaying antibody variable domains

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Phage libraries for generation of clinically useful antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Isolation of high affinity human antibodies directly from large synthetic repertoires.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

The contribution of contact and non-contact residues of antibody in the affinity of binding to antigen. The interaction of mutant D1.3 antibodies with lysozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Selection of phage antibodies by binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

High-affinity antigen binding by chelating recombinant antibodies (CRAbs).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Reshaping human antibodies for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Antigen-specific human antibodies from mice comprising four distinct genetic modifications

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

By-passing immunization: building high affinity human antibodies by chain shuffling

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Making antibodies by phage display technology

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Effect of seven new vasoactive immunoconjugates on the enhancement of monoclonal antibody uptake in tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

A recombinant single chain antibody interleukin-2 fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Recent developments in immunotoxin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Hybrid antibodies can target sites for attack by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Preliminary trial of specific targeting therapy against malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Cure of xenografted human tumors by bispecific monoclonal antibodies and human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sites

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Targeting enzymes for cancer therapy: old enzymes in new roles

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Intracellular immunization with cytosolic recombinant antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Use of N-terminal modified poly(L-lysine)-antibody conjugate as a carrier for targeted gene delivery in mouse lung endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

Retroviral vectors displaying functional antibody fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0167-7799%2800%2988968-4

7 January 2021

10.1016/S0167-7799(00)88968-4

Identifiers

DOI

1 reference

20 September 2017

1 reference

PubMed ID

7662305